Common Contracts
2 similar Note Purchase Agreement contracts by OptiNose, Inc.
AMENDED AND RESTATED NOTE PURCHASE AGREEMENT Dated as of November 21, 2022 among OPTINOSE US, INC. as the Issuer, OPTINOSE AS, as a Guarantor OPTINOSE, INC., as Parent and a Guarantor The other Guarantors from time to time party hereto, The Purchasers...Note Purchase Agreement • November 21st, 2022 • OptiNose, Inc. • Pharmaceutical preparations • New York
This AMENDED AND RESTATED NOTE PURCHASE AGREEMENT is entered into as of November 21, 2022 (the “Effective Date”) among OPTINOSE US, INC., a Delaware corporation (the “Issuer”), OPTINOSE AS, a Norwegian private limited liability company with Norwegian business registration number 982 483 131 (the “Norwegian Guarantor”), OPTINOSE, INC., a Delaware corporation (the “Parent”), the other Guarantors (defined herein) from time to time party hereto, the Purchasers (defined herein) from time to time party hereto and BIOPHARMA CREDIT PLC, a public limited company incorporated under the laws of England and Wales, as Collateral Agent.
NOTE PURCHASE AGREEMENT Dated as of September 12, 2019 among OPTINOSE US, INC. as the Issuer, OPTINOSE AS and OPTINOSE UK, LTD., as GuarantorsNote Purchase Agreement • September 12th, 2019 • OptiNose, Inc. • Pharmaceutical preparations • New York
This NOTE PURCHASE AGREEMENT is entered into as of September 12, 2019 among OPTINOSE US, INC., a Delaware corporation (the “Issuer”), OPTINOSE AS, a Norwegian private limited liability company with Norwegian business registration number 982 483 131 (the “Norwegian Guarantor”), OPTINOSE, INC., a Delaware corporation (the “Parent”), OPTINOSE UK LIMITED, a limited liability company formed under the laws of England and Wales (the “UK Guarantor”), the other Guarantors (defined herein) from time to time party hereto, the Purchasers (defined herein) from time to time party hereto and BIOPHARMA CREDIT PLC, a public limited company incorporated under the laws of England and Wales, as Collateral Agent.
